Drug Profile
Xemilofiban
Alternative Names: SC 54684; SC 54684A; XemlofibanLatest Information Update: 09 Dec 2015
Price :
$50
*
At a glance
- Originator Searle.
- Class Benzamidines; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action GPIIb-IIIa antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Myocardial infarction; Thrombosis; Unstable angina pectoris
Most Recent Events
- 09 Dec 2015 Xemilofiban is still available for out-licensing or co-development opportunities (http://www.virtualdrugdevelopment.com)
- 01 Oct 2003 Xemilofiban is available for licensing (www.vddipharmaceuticals.com)
- 12 Feb 2003 Clinical trials in Cardiovascular disorders in USA (PO)